Specify a stock or a cryptocurrency in the search bar to get a summary
FunPep Company Limited
4881FunPep Company Limited engages in the research and development of pharmaceuticals drugs, functional cosmetics, and medical devices based on functional peptides. The company is developing SR-0379, a functional peptide for skin ulcer; FPP003, an antibody-inducing peptide that is in Phase II clinical study for the treatment of psoriasis in Australia, as well as phase II clinical trial for ankylosing spondylitis in Japan; and FPP004X, an antibody-inducing peptide for pollinosis. It is also developing FPP006, a corona peptide vaccine; and FPP005, a antibody including peptide for psoriasis. FunPep Company Limited was incorporated in 2013 and is based in Tokyo, Japan. Address: No.7 Mizuho Building, Tokyo, Japan, 151-0051
Analytics
WallStreet Target Price
54 501.91 JPYP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4881
Dividend Analytics 4881
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4881
Stock Valuation 4881
Financials 4881
Results | 2019 | Dynamics |